我要投票 微医We Doctor在网上购物行业中的票数:159
· 外 推 电 报 ·
2025-02-23 19:27:47 星期日

【微医We Doctor是哪个国家的品牌?】

微医We Doctor是什么牌子?「微医We Doctor」是 杭州广发科技有限公司 旗下著名品牌。该品牌发源于浙江省杭州市,由创始人廖 * 远在2010年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力微医We Doctor品牌出海!通过在本页面挂载微医We Doctor品牌的产品链接和联系邮箱,可以提高微医We Doctor产品曝光!跨境电商爆单神器,目前只要100元/年哦~

微医是医疗健康科技平台,由廖杰远及其团队于2010年创建。以“就医不难,健康有道”为使命,微医用科技赋能医疗,驱动“医药保”生态升级,打造HMO(Health Maintenance Organization,健康维护组织)平台,为用户提供“线上+线下、全科+专科”的新型医疗健康服务。

廖杰远带领微医已在中国境内设立挂号网(杭州)科技有限公司、浙江康健绿线网络技术有限公司、绿线(杭州)信息技术有限公司、微医(杭州)集团有限公司、微医集团(浙江)有限公司、杭州广发科技有限公司、杭州萧山微医门诊部有限公司、乌镇互联网医院管理(桐乡)有限公司等多家运营实体。各大运营实体共同大力宣传、推广微医品牌各大产品及服务。

微医起步于2010年成立的挂号网,发展8年间,微医在全国医院部署了1700多套前置服务器,创造性接通医院内外网;并开创了团队医疗模式,组建了包括两院院士和国医大师在内的7500组专家团队,匹配医患,助力基层能力提升;乌镇互联网医院,并在19个省市落地;微医与全国100多家医院合作建设医联体,并搭建了包含微医全科、社区卫生服务中心和药诊店在内的1.9万家医疗健康服务网点;通过微医通、微医APP组成的软硬件终端,微医帮助亿万家庭便捷获得全时、全程的医疗健康服务。截至2018年5月,微医连接了全国30个省市的2700多家医院、24万名医生,搭建起线上线下结合、全科专科融合的医疗资源供应体系,实名注册用户数超过1.6亿,累计服务人次超过5.8亿。

在连接医院、服务政府和行业的过程中,微医积累了雄厚的健康医疗大数据资源和服务能力,形成了微医云和微医HMO两大发展战略。微医云是健康医疗行业云平台,主要面向政府、医院、基层医疗机构和企业等多类用户,提供智能医疗云和医学人工智能解决方案;微医HMO整合了微医在医疗、医药、保险领域的资源和优势,由医疗供应网络、健康管理服务和医疗保障体系共同组成,面向亿万家庭,提供“线上+线下、全科+专科”的管理式医疗健康服务。

在未来,微医将继续携手医院、医生、药企、险企、金融机构等合作伙伴,共同创建新型医疗健康服务体系,为亿万家庭的健康福祉奋力前行!


英文翻译:Micro medicine is a medical and health technology platform established by Liao Jieyuan and his team in 2010. With the mission of "medical treatment is not difficult, health is reasonable", micro medical technology enables medical treatment, drives the ecological upgrading of "medical insurance", builds the HMO (health maintenance organization) platform, and provides users with "Online + offline, general + specialty" new medical and health services. Under the leadership of Liao Jieyuan, Weiyi has established registered network (Hangzhou) Technology Co., Ltd., Zhejiang health green line network technology Co., Ltd., green line (Hangzhou) Information Technology Co., Ltd., Weiyi (Hangzhou) Group Co., Ltd., Weiyi group (Zhejiang) Co., Ltd., Hangzhou Guangfa Technology Co., Ltd., Hangzhou Xiaoshan Weiyi outpatient department Co., Ltd., Wuzhen Internet Medicine Co., Ltd Institute Management (Tongxiang) Co., Ltd. and other operating entities. All major operation entities jointly vigorously publicize and promote the major products and services of micro medicine brand. Micro medicine started from the registration network established in 2010. During the eight years of development, micro medicine has deployed more than 1700 sets of front-end servers in hospitals across the country to creatively connect the hospital's internal and external networks. It has also created a team medical model and set up 7500 groups of expert teams, including Academicians of the two academies and national medical masters, to match doctors and patients and help improve the basic level ability. Wuzhen Internet hospital has been established in 19 provinces and cities; Micro medicine cooperates with more than 100 hospitals across the country to build medical consortia, and has set up 19000 medical and health service outlets including general micro medicine department, community health service center and drug diagnosis shop; through the software and hardware terminals composed of micro medicine general and micro medicine app, micro medicine helps hundreds of millions of families get full-time and full-time medical and health services conveniently. As of May 2018, micro medicine has connected more than 2700 hospitals and 240000 doctors in 30 provinces and cities across the country, and built a medical resource supply system integrating online and offline and general practice and specialty, with more than 160 million real name registered users and more than 580 million cumulative service people. In the process of connecting hospitals, serving the government and the industry, micro medicine has accumulated abundant health care big data resources and service capabilities, and formed two development strategies, micro medicine cloud and micro medicine HMO. Micro medical cloud is a cloud platform for health care industry, which mainly provides intelligent medical cloud and medical artificial intelligence solutions for government, hospitals, grass-roots medical institutions and enterprises. Micro medical HMO integrates the resources and advantages of micro medical in the fields of medical, medicine and insurance, which is composed of medical supply network, health management services and medical security system, and is oriented to hundreds of millions of families To provide "Online + offline, general practice + specialty" management medical and health services. In the future, micro medicine will continue to work together with partners such as hospitals, doctors, pharmaceutical companies, insurance companies and financial institutions to create a new medical and health service system and strive for the health and well-being of hundreds of millions of families!

本文链接: https://www.waitui.com/brand/8fb2c6f82.html

千城特选小程序码

7×24h 快讯

天岳先进:2024年净利润1.8亿元 同比扭亏为盈

36氪获悉,天岳先进发布业绩快报,公司2024年实现营业收入17.68亿元,同比增长41.37%;实现归属于母公司所有者的净利润1.80亿元,同比扭亏为盈。主要原因是公司大尺寸、导电型产品产能产量持续提升,销售量增加,同时产品毛利率上升。

2小时前

小米集团卢伟冰:小米15 Ultra会是越级式的一代产品

36氪获悉,小米集团合伙人兼总裁、手机部总裁、小米品牌总经理卢伟冰发文称,小米手机未来5年高端化的目标之一,就是要在6000元+价格段实现规模化的突破,“Ultra是6K+突破的关键产品,而小米15 Ultra会是越级式的一代产品”。

2小时前

恒瑞医药:羟乙磺酸达尔西利片联合内分泌治疗乳腺癌III期临床试验达主要终点

36氪获悉,恒瑞医药公告称,公司自主研发的羟乙磺酸达尔西利片在激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性女性乳腺癌辅助治疗的III期临床试验中,首次期中分析主要终点达到统计学显著性。研究结果显示,达尔西利联合内分泌治疗可显著降低患者复发风险,提高患者无侵袭性疾病生存期(IDFS)。公司已向国家药品监督管理局药品审评中心递交上市前沟通交流申请。该药品是公司自主研发的化学药品1类新药,是一种口服、高效、选择性的小分子CDK4/6抑制剂。

2小时前

深圳:近期将发布人形机器人专项政策 在全市科技重大专项中安排人工智能和机器人专项

深圳市政府新闻办2月23日召开“打造最好科技创新生态和人才发展环境”主题新闻发布会。市人工智能产业办主任林毅在会上表示,深圳在人工智能和机器人领域基础雄厚、未来可期。下一步,我们将在政策、场景、创新、机器人四个方面持续发力。此外,近期我们还将发布人形机器人专项政策,通过“揭榜挂帅”等方式,对开放应用场景、突破关键技术、构建专用数据集、提升规模化制造和应用能力等予以精准支持。同时,还将在全市科技重大专项中安排人工智能和机器人专项,鼓励产、学、研、用组成创新联合体进行协同攻关。(财联社)

2小时前

一汽大众ID.系列部分车型官降至高5.5万元

一汽-大众宣布对旗下ID.系列部分车型进行降价,最高降幅达5.5万元。此次降价活动涉及ID.4 CROZZ和ID.6 CROZZ两款车型,无门槛一口价分别为13.99万元和19.59万元起,还可叠加官方置换补贴至高1万元、国家置换补贴至高2万元。(财联社)

2小时前

本页详细列出关于互动百科的品牌信息,含品牌所属公司介绍,互动百科所处行业的品牌地位及优势。
咨询